Cytotoxic FCER1G+ innate-like T cells: new potential for tumour immunotherapy

Cytotoxic FCER1G+ innate-like T cells: new potential for tumour immunotherapy

Bibliographic Details
Main Authors:	Emma Morrish, Jürgen Ruland
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-06-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-022-01061-4

Similar Items

Comprehensive analysis reveals the tumor suppressor role of macrophage signature gene FCER1G in hepatocellular carcinoma
by: Deyu Kong, et al.
Published: (2025-02-01)

Prognostic value of FCER1G expression and M2 macrophage infiltration in esophageal squamous cell carcinoma
by: Wei Peng, et al.
Published: (2025-02-01)

Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM.
by: Frances M Bashore, et al.
Published: (2024-01-01)

Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM
by: Frances M. Bashore, et al.
Published: (2024-01-01)

Identification of FCER1G as a key gene in multiple myeloma based on weighted gene co-expression network analysis
by: Xiao Qiu, et al.
Published: (2023-12-01)

Emerging roles of type 1 innate lymphoid cells in tumour pathogenesis and cancer immunotherapy
by: James Michael Verner, et al.
Published: (2024-04-01)

Development of a time-resolved fluorescence resonance energy transfer ultra-high throughput screening assay targeting SYK and FCER1G interaction
by: Yuhong Du, et al.
Published: (2024-09-01)

Identification of FCER1G related to Activated Memory CD4+ T Cells Infiltration by Gene Co-expression Network and Construction of a Risk Prediction Module in Diffuse Large B-Cell Lymphoma
by: Xiaoyu Xiang, et al.
Published: (2022-05-01)

Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
by: Fernando Torres Andón, et al.
Published: (2022-07-01)

How G4 ligands enhance the innate immune response in BRCA1/2- deficient cells and tumours
by: De Visser, Y, et al.
Published: (2020)

A Co-Expressed Natural Antisense RNA FCER1A-AS Controls IgE-Dependent Immunity by Promoting Expression of FcεRIα
by: Ruo-yu Tang, et al.
Published: (2023-06-01)

Innate–Acquired Linkage in Immunotherapy
by: Tsukasa Seya
Published: (2023-01-01)

P06.01 Gain-of-function CARD11 signalling in B cells causes pathological lymphoproliferative disease in mice which is strictly dependent on MALT1 activity
by: J Ruland, et al.
Published: (2024-03-01)

Prediction of asthma using a four-locus gene model including IL13, IL4, FCER1B, and ADRB2 in children of Kazak nationality
by: Shasha Bai, et al.
Published: (2023-12-01)

B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
by: Xinyu Tian, et al.
Published: (2023-10-01)

Editorial: Therapeutic potential of innate and innate-like effector lymphocytes in autoimmune and inflammatory diseases
by: Lan Wu, et al.
Published: (2023-10-01)

Roles for Innate Immunity in Combination Immunotherapies
by: Moynihan, Kelly Dare, et al.
Published: (2018)

Targeting Innate Immune Cells for Immunotherapy
by: Leandro J. Carreño, et al.
Published: (2017-01-01)

Exploiting innate immunity for cancer immunotherapy
by: Ming Yi, et al.
Published: (2023-11-01)

Innate immunity and immunotherapy for hemorrhagic shock
by: Qingxia Huang, et al.
Published: (2022-08-01)

Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.
by: Klimek, L, et al.
Published: (2014)

Editorial: New insights into innate immune cell-based immunotherapies in cancer
by: Anne Caignard, et al.
Published: (2024-04-01)

Tumour cytotoxic agent and methods thereof.
by: Foo, Hooi Ling, et al.
Published: (2012)

Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy
by: Michael Hiltensperger, et al.
Published: (2024-04-01)

Metabolic regulation of innate immunity in cancer immunotherapy
by: Yuheng Liao, et al.
Published: (2023-12-01)

Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies
by: Sara Small, et al.
Published: (2021-11-01)

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
by: Adrian von Witzleben, et al.
Published: (2020-09-01)

Knowing the tumour microenvironment to optimise immunotherapy
by: M. C. Merlano, et al.
Published: (2019-02-01)

The effect of Staphylococcus aureus on innate and adaptive immunity and potential immunotherapy for S. aureus-induced osteomyelitis
by: Yingqi Chen, et al.
Published: (2023-09-01)

FTO attenuates the cytotoxicity of cisplatin in KGN granulosa cell-like tumour cells by regulating the Hippo/YAP1 signalling pathway
by: Rongli Wang, et al.
Published: (2024-03-01)

Alterations of the Innate Immune System in Susceptibility and Resilience After Social Defeat Stress
by: Oliver Ambrée, et al.
Published: (2018-07-01)

CARD9 Signaling in Intestinal Immune Homeostasis and Oncogenesis
by: Lara Hartjes, et al.
Published: (2019-03-01)

The potential for Toll-like receptors to collaborate with other innate immune receptors.
by: Mukhopadhyay, S, et al.
Published: (2004)

The Role of Innate Lymphoid Cells in Cancer Development and Immunotherapy
by: Rio Sugimura, et al.
Published: (2022-04-01)

Nanomaterials for modulating innate immune cells in cancer immunotherapy
by: Quoc-Viet Le, et al.
Published: (2019-01-01)

Fatty acid metabolism of immune cells: a new target of tumour immunotherapy
by: Sheng Zhang, et al.
Published: (2024-01-01)

In vivo discovery of immunotherapy targets in the tumour microenvironment
by: Zhou, Penghui, et al.
Published: (2014)

Targeting the hypoxic tumour phenotype with T-cell immunotherapy
by: Chong, T
Published: (2004)

Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth
by: Oon, C, et al.
Published: (2017)

Tissue-Resident Innate and Innate-Like Lymphocyte Responses to Viral Infection
by: Andrew D. Hildreth, et al.
Published: (2019-03-01)